ZA855399B - Use of xanthine and thioxanthine derivatives for the preparation of medicaments - Google Patents
Use of xanthine and thioxanthine derivatives for the preparation of medicamentsInfo
- Publication number
- ZA855399B ZA855399B ZA855399A ZA855399A ZA855399B ZA 855399 B ZA855399 B ZA 855399B ZA 855399 A ZA855399 A ZA 855399A ZA 855399 A ZA855399 A ZA 855399A ZA 855399 B ZA855399 B ZA 855399B
- Authority
- ZA
- South Africa
- Prior art keywords
- xanthine
- medicaments
- preparation
- thioxanthine derivatives
- thioxanthine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB848418430A GB8418430D0 (en) | 1984-07-19 | 1984-07-19 | Treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA855399B true ZA855399B (en) | 1987-03-25 |
Family
ID=10564129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA855399A ZA855399B (en) | 1984-07-19 | 1985-07-17 | Use of xanthine and thioxanthine derivatives for the preparation of medicaments |
Country Status (7)
Country | Link |
---|---|
US (1) | US4657910A (ja) |
EP (1) | EP0173039A3 (ja) |
JP (2) | JPS6140288A (ja) |
AU (1) | AU581672B2 (ja) |
DK (1) | DK325285A (ja) |
GB (1) | GB8418430D0 (ja) |
ZA (1) | ZA855399B (ja) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4808619A (en) * | 1983-07-27 | 1989-02-28 | Beecham Group P.L.C. | Di/tetra-hydroquinolines |
GB8621869D0 (en) * | 1986-09-11 | 1986-10-15 | Beecham Group Plc | Treatment |
US4965271A (en) * | 1986-12-31 | 1990-10-23 | Hoechst Roussel Pharmaceuticals, Inc. | Method of inhibiting the activity of leukocyte derived cytokines |
IL106861A (en) * | 1986-12-31 | 1997-02-18 | Hoechst Roussel Pharma | Pentoxifylline metabolites and pharmaceutical formulations containing them for inhibiting the activity of interleukin-1 and leukocyte-derived cytokines |
US5096906A (en) * | 1986-12-31 | 1992-03-17 | University Of Virginia Alumni Patents Foundation | Method of inhibiting the activity of leukocyte derived cytokines |
JP2661666B2 (ja) * | 1988-02-19 | 1997-10-08 | ヘキスト薬品工業株式会社 | 抗消化性潰瘍剤 |
US5321029A (en) * | 1988-11-14 | 1994-06-14 | Beecham-Wuelfing Gmbh & Co.K.G. | Xanthines |
GB8921029D0 (en) * | 1989-09-16 | 1989-11-01 | Beecham Wuelfing Gmbh & Co Kg | Novel treatment |
US6420374B1 (en) | 1990-11-30 | 2002-07-16 | Fred Hutchinson Cancer Research Center | Use of xanthines as immunosuppressants and to inhibit allograft reactions |
EP1034791A1 (en) * | 1997-11-28 | 2000-09-13 | Nikolai Vasilievich Karsanov | Anti-hypoxic and anti-ischemic drug |
TW200804383A (en) * | 2006-06-05 | 2008-01-16 | Astrazeneca Ab | New compounds |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH608236A5 (ja) * | 1974-01-22 | 1978-12-29 | Wuelfing J A Fa | |
FR2387035A1 (fr) * | 1977-04-12 | 1978-11-10 | Cassenne Lab Sa | Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux |
EP0005015B1 (en) * | 1978-04-22 | 1986-10-29 | BEECHAM - WUELFING GmbH & Co. KG | Use of a xanthine derivate in the manufacture of a medicament |
IL59664A0 (en) * | 1979-04-05 | 1980-06-30 | Wuelfing J Kg | Xanthine derivatives,process for their preparation and their use in pharmaceutical compositions |
IL59665A0 (en) * | 1979-04-05 | 1980-06-30 | Wuelfing J Kg | Xanthine derivatives,process for their preparation and their use in pharmaceutical compositions |
US4225607A (en) * | 1979-05-14 | 1980-09-30 | Johann A. Wulfing | Pharmaceutical composition containing a xanthine derivative |
DE2929596A1 (de) * | 1979-07-21 | 1981-02-05 | Hoechst Ag | Verfahren zur herstellung von oxoalkyl-xanthinen |
EP0157098A1 (en) * | 1980-06-21 | 1985-10-09 | Beecham Wuelfing GmbH & Co KG | Xanthine derivatives, pharmaceuticals compositions containing them and a process for their preparation |
-
1984
- 1984-07-19 GB GB848418430A patent/GB8418430D0/en active Pending
-
1985
- 1985-07-10 EP EP85108610A patent/EP0173039A3/en not_active Ceased
- 1985-07-17 DK DK325285A patent/DK325285A/da not_active Application Discontinuation
- 1985-07-17 ZA ZA855399A patent/ZA855399B/xx unknown
- 1985-07-18 JP JP15928885A patent/JPS6140288A/ja active Pending
- 1985-07-19 AU AU45175/85A patent/AU581672B2/en not_active Ceased
-
1986
- 1986-03-06 US US06/837,014 patent/US4657910A/en not_active Expired - Fee Related
-
1989
- 1989-11-14 JP JP1296017A patent/JPH02160720A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US4657910A (en) | 1987-04-14 |
AU4517585A (en) | 1986-01-23 |
EP0173039A3 (en) | 1988-09-14 |
AU581672B2 (en) | 1989-03-02 |
JPH02160720A (ja) | 1990-06-20 |
EP0173039A2 (en) | 1986-03-05 |
DK325285A (da) | 1986-01-20 |
DK325285D0 (da) | 1985-07-17 |
GB8418430D0 (en) | 1984-08-22 |
JPS6140288A (ja) | 1986-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0182024A3 (en) | Purine derivatives and their pharmaceutical use purine derivatives and their pharmaceutical use | |
AU581507B2 (en) | 8-Substituted phenyl-xanthine derivatives and their pharmaceutical use | |
NZ216888A (en) | Tertiary hydroxyalkyl substituted xanthines and pharmaceutical compositions | |
PT81859A (en) | Thiazolidinedione derivatives their production and use | |
PH23495A (en) | Phenoxyalkylaminopyrimidine derivatives and the composition and method of use thereof | |
NZ220214A (en) | 3-aminopyrazole derivatives and pharmaceutical compositions | |
NZ216951A (en) | Pyrimidine derivatives and pharmaceutical compositions | |
GR860849B (en) | 4-demethyl -4- epipodophyllotoxin derivatives process for their preparation and their use as medicaments | |
GR3030150T3 (en) | Use of Human Interferon-Beta 2A for the preparation of medicaments | |
NZ217220A (en) | Guanine derivatives and pharmaceutical compositions | |
NZ213798A (en) | Guanine derivatives and pharmaceutical compositions | |
ZA855399B (en) | Use of xanthine and thioxanthine derivatives for the preparation of medicaments | |
NZ212060A (en) | Bicyclic hetrocycles and pharmaceutical derivatives | |
GR862211B (en) | Azolyl-cyclopropyl-ethanol derivatives methods for their preparation and their use | |
IL80109A0 (en) | 6,9-substituted purines,pharmaceutical compositions containing them and processes for their preparation | |
NZ217448A (en) | Xanthine derivatives and pharmaceutical compositions | |
NZ219250A (en) | Purine derivatives and pharmaceutical compositions | |
GB8628049D0 (en) | Use of tetrahydrobenzothienylurea derivatives | |
NZ217068A (en) | Substituted thiazolone derivatives and pharmaceutical use | |
NZ224307A (en) | Preparation of purine derivatives and pharmaceutical compositions | |
DE3664768D1 (en) | 5-phenyl-1,4,5,6-tetrahydropyrimidine derivatives, preparation process and medicinal use | |
SG116193G (en) | Purine derivatives and their pharmaceutical use | |
ZA867229B (en) | 2-aminopurines substituted in the 6-and 9-position,their use,medicaments containing these purines,and processes for the preparation of the purines | |
AU589724B2 (en) | Piperazine derivatives of theophylline and theobromine | |
EP0223701A3 (en) | Use of ergoline derivatives in the preparation of a neural protective medicament |